Cardinal Capital Management Acquires 3,379 Shares of Agilent Technologies, Inc. (NYSE:A)

Cardinal Capital Management increased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 5.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 64,609 shares of the medical research company’s stock after buying an additional 3,379 shares during the period. Cardinal Capital Management’s holdings in Agilent Technologies were worth $3,832,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the stock. Cribstone Capital Management LLC increased its stake in shares of Agilent Technologies by 2.3% in the first quarter. Cribstone Capital Management LLC now owns 2,359 shares of the medical research company’s stock valued at $125,000 after buying an additional 54 shares during the last quarter. Fox Run Management L.L.C. increased its position in Agilent Technologies by 111.0% in the first quarter. Fox Run Management L.L.C. now owns 21,947 shares of the medical research company’s stock valued at $1,160,000 after buying an additional 11,547 shares during the last quarter. Private Trust Co. NA increased its position in Agilent Technologies by 2.1% in the first quarter. Private Trust Co. NA now owns 7,660 shares of the medical research company’s stock valued at $404,000 after buying an additional 161 shares during the last quarter. Capstone Asset Management Co. increased its position in Agilent Technologies by 7.4% in the first quarter. Capstone Asset Management Co. now owns 43,126 shares of the medical research company’s stock valued at $2,280,000 after buying an additional 2,990 shares during the last quarter. Finally, Quadrant Capital Group LLC increased its position in Agilent Technologies by 0.9% in the first quarter. Quadrant Capital Group LLC now owns 5,470 shares of the medical research company’s stock valued at $284,000 after buying an additional 50 shares during the last quarter.

Agilent Technologies, Inc. (NYSE A) traded up 1.30% during trading on Friday, hitting $59.33. The company’s stock had a trading volume of 1,511,552 shares. The firm has a market cap of $19.06 billion, a PE ratio of 33.35 and a beta of 1.30. The company has a 50-day moving average of $60.10 and a 200 day moving average of $55.69. Agilent Technologies, Inc. has a one year low of $42.92 and a one year high of $61.84.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, May 22nd. The medical research company reported $0.58 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.48 by $0.10. Agilent Technologies had a net margin of 13.41% and a return on equity of 16.49%. The business had revenue of $1.10 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the previous year, the business earned $0.44 earnings per share. The firm’s revenue was up 8.1% compared to the same quarter last year. On average, equities analysts forecast that Agilent Technologies, Inc. will post $2.23 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 26th. Stockholders of record on Monday, July 3rd were issued a dividend of $0.132 per share. The ex-dividend date of this dividend was Thursday, June 29th. This represents a $0.53 dividend on an annualized basis and a dividend yield of 0.89%. Agilent Technologies’s dividend payout ratio is currently 29.78%.

ILLEGAL ACTIVITY NOTICE: “Cardinal Capital Management Acquires 3,379 Shares of Agilent Technologies, Inc. (NYSE:A)” was published by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://stocknewstimes.com/2017/08/12/agilent-technologies-inc-nysea-stake-increased-by-cardinal-capital-management-updated.html.

Several analysts have issued reports on the company. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $63.00 target price on the stock in a research report on Tuesday, May 16th. Deutsche Bank AG increased their target price on Agilent Technologies from $58.00 to $62.00 and gave the company a “buy” rating in a research report on Monday, May 22nd. Cowen and Company increased their target price on Agilent Technologies from $53.00 to $62.00 and gave the company a “market perform” rating in a research report on Tuesday, May 23rd. Jefferies Group LLC increased their target price on Agilent Technologies from $59.00 to $66.00 and gave the company a “buy” rating in a research report on Tuesday, May 23rd. Finally, Robert W. Baird raised their price objective on Agilent Technologies from $57.00 to $62.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 24th. Two research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Agilent Technologies currently has a consensus rating of “Buy” and a consensus price target of $60.12.

In other Agilent Technologies news, insider Patrick Kaltenbach sold 2,074 shares of the company’s stock in a transaction that occurred on Wednesday, May 31st. The shares were sold at an average price of $60.43, for a total value of $125,331.82. Following the transaction, the insider now owns 42,212 shares in the company, valued at approximately $2,550,871.16. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Paul N. Clark sold 3,866 shares of the company’s stock in a transaction that occurred on Thursday, May 25th. The shares were sold at an average price of $59.05, for a total transaction of $228,287.30. The disclosure for this sale can be found here. Insiders have sold 112,608 shares of company stock worth $6,737,509 in the last 90 days.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply